Psychiatry

Addressing New York's Youth Mental Health Crisis, Montefiore Announces Plans for New Pediatric Inpatient Psychiatry Unit

Retrieved on: 
Wednesday, March 6, 2024
New York State Assembly, Anxiety, Mental health, New Yorker, Adolescence, Suicidal ideation, Education, HRSA, Montefiore Medical Center, Hospital, Bed, Assembly, Mental, JAMA, Psychosis, Behavioural sciences, Depression, Patient, Pediatrics, Child, Psychiatry, Trauma, Environment, Travel, Intensive outpatient program, Nursing

BRONX, N.Y., March 6, 2024 /PRNewswire/ -- Montefiore today announced plans for a new pediatric inpatient psychiatry unit adding a new care option to address the unmet urgent behavioral and mental health needs of children and adolescents in the Bronx. The Montefiore Einstein Center for Children's Mental Health of the Children's Hospital at Montefiore Einstein will be funded in part by a nearly $6 million appropriation to Montefiore spearheaded by New York State Assembly Speaker Carl Heastie and Assembly Member Michael Benedetto. The 21-bed child and adolescent unit will be located within the New York City Children's Center (NYCCC) campus adjacent to the Albert Einstein College of Medicine and will serve as a model for urban pediatric inpatient psychiatric services. The new program will physically and programmatically extend the capacity of CHAM to provide a full range of medical and behavioral health services for youth in the region. The proposed center will be designed to provide best-in-class intensive treatment for youth with serious behavioral health conditions including severe depression, anxiety, trauma, suicidal thoughts, psychosis and other acute psychiatric conditions.

Key Points: 
  • BRONX, N.Y., March 6, 2024 /PRNewswire/ -- Montefiore today announced plans for a new pediatric inpatient psychiatry unit adding a new care option to address the unmet urgent behavioral and mental health needs of children and adolescents in the Bronx.
  • The new program will physically and programmatically extend the capacity of CHAM to provide a full range of medical and behavioral health services for youth in the region.
  • As a leading health system in New York renowned for delivering exceptional care, I am confident that Montefiore will exceed in tackling mental health disparities with the new pediatric psychiatry unit," said New York State Assembly Speaker Carl Heastie.
  • The Montefiore pediatric psychiatry unit will provide 24/7 best-in-class care and access to comprehensive evaluation and care administered by mental health professionals expert in pediatric psychiatry.

Magellan Health Introduces Digital Cognitive Behavioral Therapy Programs for Children and Adolescents

Retrieved on: 
Tuesday, March 5, 2024
Anxiety, Mental health, COVID-19, Adolescence, Ferdinand Magellan, Cognitive behavioral therapy, Pediatrics, Psychiatry, Magellan Health, Bentham Science Publishers, Pediatrics (journal), American Academy, Nursing

FRISCO, Texas, March 5, 2024 /PRNewswire/ -- Magellan Health, Inc., a leader in behavioral health and related services, today announced two new digital cognitive behavioral therapy (DCBT) programs for children and adolescents struggling with anxiety-related symptoms.

Key Points: 
  • FRISCO, Texas, March 5, 2024 /PRNewswire/ -- Magellan Health, Inc. , a leader in behavioral health and related services, today announced two new digital cognitive behavioral therapy (DCBT) programs for children and adolescents struggling with anxiety-related symptoms.
  • These new programs enhance Magellan's existing evidence-based, award-winning Digital Emotional Wellbeing program, powered by NeuroFlow .
  • These tools also extend the capacity of clinicians to care for children in the primary care space," said Caroline Carney, M.D., president of behavioral health and chief medical officer of Magellan Health.
  • "These new programs demonstrate Magellan's commitment to integrating digital tools within the healthcare experience to help members build thriving lives, resilient minds and healthy bodies."

Gateways Hospital and Mental Health Center Opens New Sensory Room, Providing Vulnerable Clients with Innovative, Client-Centered Care

Retrieved on: 
Friday, March 1, 2024
Gateways, Anxiety, Mental health, Caregiver, Adolescence, Emotion, LOS, Occupational therapy, Hospital, Patient, Sound, Royal college, Sensory room, Employment, Health, Agitation, Lighting, Psychiatry, Self-management, Environment, Nursing

LOS ANGELES, March 1, 2024 /PRNewswire/ -- Gateways Hospital and Mental Health Center unveiled its groundbreaking Sensory Room, a pioneering addition to acute patient care in Los Angeles, generously funded by a $45,000 grant from the Robert Ellis Simon Foundation. This innovative space signifies Gateways' commitment to implementing client-centered approaches, blending the latest inpatient psychiatric care practices with immersive sensory interventions, meaningful activities, and fostering connections between clients and caregivers.

Key Points: 
  • Colleen Carroll, Occupational Therapy Director at Gateways Mental Health Center and Hospital, expressed enthusiasm about the sensory room's impact, stating, "Gateways prioritizes resources that prioritize our clients' well-being.
  • Guided by Gateways' mental health professionals, clients can customize their sensory experiences by adjusting lighting, sound, and tactile elements, granting them autonomy over their care.
  • "This grant empowers us to redefine acute mental health care by providing a safe, engaging experience for our clients," said Dr. Wong.
  • "Gateways' Sensory Room sets a new standard for patient-centered care, aligning with our mission to empower individuals in their mental health journey."

First-of-its-Kind Study Reveals Potential Impact of Behavioral Health Crisis Systems on Reducing Costly, Avoidable Hospital Events

Retrieved on: 
Wednesday, February 28, 2024
SAMHSA, Research, Bed, Substance Abuse, Psychiatric Services, Hospital, Health information management, University, Suicide, Medicaid, AHCCCS, Psychiatry

PHOENIX, Feb. 28, 2024 /PRNewswire/ -- Access to a comprehensive behavioral health crisis response system can lessen demand for more restrictive and costly emergency department and inpatient services, according to a new research study published in the journal Psychiatric Services. The study was conducted by a team that included researchers from Arizona State University Center for Health Information and Research and Connections Health Solutions.

Key Points: 
  • The study was conducted by a team that included researchers from Arizona State University Center for Health Information and Research and Connections Health Solutions .
  • The analysis revealed:
    The majority of individuals (57.4%) entered the crisis system through mobile crisis or crisis facilities versus the emergency department, indicating the crucial role these services play in crisis response.
  • Of individuals who did reutilize services, the majority (73.0%) utilized mobile or facility-based crisis services rather than emergency department or inpatient services, affirming the significance of crisis systems in preventing hospital utilization.
  • "This study shows that crisis systems can serve a large proportion of individuals in crisis, reducing the need for more restrictive and costly levels of care."

The Ad Council, Coalition of Health Systems and Hospitals Tackle America's Most Urgent Public Health Crisis: Gun Violence

Retrieved on: 
Tuesday, February 27, 2024
Bias, Hospital, Social change, Education, MedStar Health, Injury, Gun, Love, City, Children's Hospital Association, Study, Death, Ad Council, University, Policy, Medical Center, Council, Marketing, Wound, Health, Hatred, Interim, Advertising, Trauma, Johns Hopkins, ACRI, Gun violence, Pediatrics, Psychiatry, CDC, Firearm, Pediatrics (journal), Partnership, Elective surgery, Mental health, Intermountain Health, Multimedia, The Jed Foundation, Northwell Health, KFF, University of Washington, Epidemiology, Research, American Academy, National health insurance, Risk, COVID-19, Patient, Smokey Bear, Public, Nursing

NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Today at Northwell Health's 5th annual Gun Violence Prevention Forum, the Ad Council announced a new gun violence prevention initiative in collaboration with a coalition of health care leaders to address this urgent public health crisis and its impact on youth.

Key Points: 
  • This group of chief executives represents some of the nation's largest health systems and hospitals that are providing funding, strategic insight and issue expertise on gun violence prevention for the campaign.
  • However, only 26% selected gun injuries as the leading cause of death among children, demonstrating a need for further education.
  • Health systems and hospitals throughout the country have seen firsthand the toll gun violence takes on communities.
  • This includes a coalition-based and multi-audience approach, mobilizing the advertising, media and marketing industries to tackle gun violence prevention in America.

Accolade Welcomes Brightline to Trusted Partner Ecosystem

Retrieved on: 
Tuesday, February 27, 2024
Anxiety, Mental health, Caregiver, Adolescence, American Academy, ACCD, Lyra, Parent, Headspace, Health, Accolade, Nursing care plan, Frustration, Depression, Family, Burnout, ADHD, Psychiatry, Trusted Partner, Equip, Bentham Science Publishers, Partnership, Nursing

SEATTLE, Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem. The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.

Key Points: 
  • Partnership expands access to high-quality, affordable adolescent and children's behavioral health services
    SEATTLE, Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem.
  • The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.
  • We help them move through the daunting barriers to care access," said Nancy Costlow, Accolade Senior Director, Clinical Shared Services.
  • We are thrilled to partner with Accolade to help drive awareness of Brightline's solution and improve access to a critical benefit that is missing for many families today."

Matter Neuroscience Secures $26M in Funding to Cure Unhappiness

Retrieved on: 
Tuesday, February 27, 2024
Neuroimaging, DEPT, Happiness, Diagnosis, Anxiety, Mental health, Interventional radiology, Emotion, Research, Biomedical engineering, Professor, Collaborative Fund, Capitalism, Polaris Partners, Capital, Imaging, Neurology, Risk, Trial of the century, Health, Human Brain Project, Medical imaging, Brain mapping, ARCH, Bayer, Bouchon, Maastricht University, Biological engineering, Psychiatry, Science, Magnetic resonance, ARCH Venture Partners, Good Worldwide, Addiction, Brain, Depression

NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Matter Neuroscience, the company working to unlock a deeper understanding of happiness and well-being by providing people with personalized insights into their brain chemistry emerges from stealth mode today. Matter announced it has received $26 million in funding, initial funding seeded by Polaris Partners and a more recent round co-led by ARCH Venture Partners, Polaris Partners, and Exor Ventures, and joined by Collaborative Fund and others. With this backing, Matter will bolster its efforts to pioneer solutions that address the unhappiness epidemic by transforming our understanding and management of mental well-being.

Key Points: 
  • With this backing, Matter will bolster its efforts to pioneer solutions that address the unhappiness epidemic by transforming our understanding and management of mental well-being.
  • Together with its collaboration partners, Matter Neuroscience will initiate three more clinical studies in 2024.
  • Matter also offers users access to educational materials and a lecture series on the neuroscience of happiness.
  • Matter Neuroscience was co-founded in 2019 with Ben Goldhirsh of GOOD Worldwide and the Goldhirsh Foundation, and Chris Shiflett of Faculty and Brooklyn Beta.

Rodin Books announces the release of "Big Bet Leadership: Your Transformation Playbook for Winning in the Hyper-Digital Era"

Retrieved on: 
Tuesday, February 27, 2024
Virtue, Amazon Marketplace, Playbook, T-Mobile, PARC, Culture, Risk, AlixPartners, Stanford University, McCaffrey, GPT, Psychiatry, Organization, FBI, TrueBlue, Amazon, UCLA, Just Listen, Research, Book, Management

NEW YORK, Feb. 27, 2024 /PRNewswire-PRWeb/ -- Rodin Books, a leading publisher in business and leadership literature, announces the release of Big Bet Leadership: Your Transformation Playbook for Winning in the Hyper-Digital Era by renowned authors and advisors John Rossman and Kevin McCaffrey. This groundbreaking book is available in hardcover, e-book, and audio formats across all major retail platforms.

Key Points: 
  • NEW YORK, Feb. 27, 2024 /PRNewswire-PRWeb/ -- Rodin Books, a leading publisher in business and leadership literature, announces the release of Big Bet Leadership: Your Transformation Playbook for Winning in the Hyper-Digital Era by renowned authors and advisors John Rossman and Kevin McCaffrey.
  • "In a business environment that's more volatile and competitive than ever, Big Bet Leadership provides counter-intuitive and provocative tactics for systematic growth," said Arthur Klebanoff, CEO of Rodin Books.
  • Big Bet Leadership emerges as a crucial playbook for today's senior leadership facing the daunting task of steering their organizations through transformative changes and innovations.
  • The book covers Big Bet Thinking, Big Bet Environment and Big Bet Management, ensuring that leaders create clarity, maintain velocity and prioritize risk and value effectively.

Circular Genomics Strengthens Leadership Team with Key Commercial and Research Hires

Retrieved on: 
Monday, February 26, 2024
SSRI, Senior, Champaign–Urbana metropolitan area, Green belt, Management, Clinical research, Kellogg School of Management, MBA, Molecular biology, Psychiatry, Miami University, University, Hologic, RNA, Society, Biomarker, DSM-IV codes, Medicine, Technologist, Novartis, Neurology, Genomics, Exact sciences, IVD

ALBUQUERQUE, N.M., Feb. 26, 2024 /PRNewswire/ -- Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the appointments of Dave Karlander as Chief Commercial Officer and Vishi Srinivasan, Ph.D., as Senior Director of Clinical Research. In these new roles, Karlander will oversee and manage all commercial aspects of the company's operations, including sales, product marketing and managed care; and Dr. Srinivasan will drive the advancement of Circular Genomics' clinical pipeline and strategy for the development of circular RNA-based tests in psychiatric and neurologic disorders.

Key Points: 
  • ALBUQUERQUE, N.M., Feb. 26, 2024 /PRNewswire/ -- Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the appointments of Dave Karlander as Chief Commercial Officer and Vishi Srinivasan, Ph.D., as Senior Director of Clinical Research.
  • In these new roles, Karlander will oversee and manage all commercial aspects of the company's operations, including sales, product marketing and managed care; and Dr. Srinivasan will drive the advancement of Circular Genomics' clinical pipeline and strategy for the development of circular RNA-based tests in psychiatric and neurologic disorders.
  • "I am delighted to welcome both Dave and Vishi to our leadership team at Circular Genomics," said Dr. Paul Sergeant, Chief Executive Officer of Circular Genomics.
  • "Dave's extensive background in commercial operations, including leading several product launches, will be invaluable during this stage at our company.

Psychedelics set to be the revolutionary treatments in pscyhiatry- Thelansis Knowledge Partners

Retrieved on: 
Thursday, February 22, 2024
Knowledge, DSM-IV codes, Esketamine, TRD, Major depressive disorder, Drug development, TAS, USFDA, Psilocybin, MDMA, Psychiatry, CNS, Patient, Acute stress disorder, PTSD, Polypharmacy, Psychotherapy, MDD, KOL, Research, Central nervous system disease, Pharmaceutical industry

Availability of psychedelic(s) with few administrations in a year and offering high remission rate could change the treatment pathway for these patients."

Key Points: 
  • Availability of psychedelic(s) with few administrations in a year and offering high remission rate could change the treatment pathway for these patients."
  • According to an interviewed U.S.-based neurologist by Thelansis – "We desperately need disease-modifying treatments for many neurodegenerative conditions.
  • As psychedelics would be beneficial for treatment-nonresponders or severe patients, the commercial opportunities are multiple for in-pipeline psychedelic therapies.
  • What is the probable opportunity for Psychedelics (e.g., psilocybin, MDMA) to address the unmet needs of other TAs?